SanBio Company Limited
SNBIF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $2 | $3 | $6 | $5 |
| G&A Expenses | $0 | $0 | $2 | $2 |
| SG&A Expenses | $1 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $4 | $5 | $8 | $7 |
| Operating Income | -$4 | -$5 | -$8 | -$7 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1 | $2 | $3 | $2 |
| Pre-Tax Income | -$3 | -$3 | -$5 | -$5 |
| Tax Expense | $0 | $0 | $1 | $0 |
| Net Income | -$3 | -$3 | -$6 | -$5 |
| % Margin | – | – | – | – |
| EPS | -41.85 | -40.48 | -95.99 | -90.33 |
| % Growth | -3.4% | 57.8% | -6.3% | – |
| EPS Diluted | -41.85 | -40.48 | -95.99 | -90.33 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$4 | -$5 | -$5 | -$4 |
| % Margin | – | – | – | – |